Calculate International Normalized Ratio from PT and ISI, then compare the result with common therapeutic ranges in one anticoagulation reference worksheet.
The International Normalized Ratio (INR) is the standardized form of the prothrombin time (PT) test. It was designed so PT results from different laboratories and thromboplastin reagents can be compared more consistently by using the reagent-specific International Sensitivity Index (ISI).
INR monitoring remains central for patients taking warfarin. The usual target range depends on the indication — commonly 2.0–3.0 for atrial fibrillation or venous thromboembolism, and often 2.5–3.5 for some mechanical-valve settings.
This calculator keeps the key INR pieces together in one reference worksheet: the entered INR, an optional PT/ISI cross-check, the usual therapeutic range for the selected indication, a simple bleeding-risk context, and common interaction reminders. It is an interpretation aid, not a dosing or reversal protocol.
INR interpretation depends on both the current value and the indication being treated. This page keeps the therapeutic range, PT/ISI cross-check, and interaction context together so the result can be reviewed without turning the calculator into a stand-alone dosing engine.
INR = (Patient PT / Control PT)^ISI. Therapeutic range: 2.0–3.0 (most indications) or 2.5–3.5 (mechanical heart valves). Dose adjustments based on American College of Chest Physicians (ACCP) guidelines.
Result: Mildly Supratherapeutic, Moderate bleeding-risk context
An INR of 3.8 is above the common 2.0–3.0 range used for atrial fibrillation. That is a useful flag for closer review, but the actual management still depends on bleeding symptoms, interacting medications, and the treating anticoagulation plan.
INR is most useful when it is paired with the anticoagulation indication. A value that is appropriate for a mechanical valve may be too high for atrial fibrillation, while a borderline low result can still matter if the patient has a high thrombotic risk.
The main drivers of INR instability are medication changes, diet changes in vitamin K intake, liver function, alcohol use, and missed doses. Warfarin is sensitive enough that even small changes can move the result out of range.
Mildly supratherapeutic values are usually handled by holding or reducing doses, while major bleeding or very high INR values require urgent reversal. That distinction is why the calculator keeps the dose-adjustment and reversal logic visible instead of reducing the result to a single number.
Last updated:
This page either uses the entered INR directly or recalculates it from patient PT, control PT, and ISI with the standard INR formula. It then compares the result with the usual therapeutic range for the selected anticoagulation indication and shows general reference context for subtherapeutic, therapeutic, and supratherapeutic values.
The output is an anticoagulation reference aid, not a dosing or reversal protocol. Dose changes, repeat-testing intervals, and reversal decisions depend on the indication, symptoms, medication list, bleeding history, and clinician-directed anticoagulation plan.
A normal INR is 0.8–1.2. Healthy individuals with normal coagulation typically have an INR of approximately 1.0.
A supratherapeutic INR increases bleeding risk, but the meaning depends on how far above range the value is, why the patient is anticoagulated, and whether there are symptoms or interacting drugs.
Every 4–6 weeks when stable and therapeutic. More frequently (1–2 weeks) after dose changes, illness, new medications, or supratherapeutic values.
Foods rich in vitamin K (leafy greens like kale, spinach, broccoli) decrease INR. The key is maintaining consistent vitamin K intake rather than avoidance.
The International Sensitivity Index (ISI) standardizes PT results across different laboratory reagents. Each thromboplastin reagent has its own ISI; values closer to 1.0 are more sensitive.
Direct oral anticoagulants (DOACs like apixaban, rivarelbaan) have replaced warfarin for many patients with atrial fibrillation and VTE. However, warfarin remains required for mechanical heart valve patients.
No. This page is meant to help interpret the INR value and its usual range context. Reversal and dose-change decisions depend on the bleeding history, indication, medication list, and clinician guidance.